A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety

被引:77
作者
Boxer, Matthew B. [1 ]
Quinn, Amy M. [1 ]
Shen, Min [1 ]
Jadhav, Ajit [1 ]
Leister, William [1 ]
Simeonov, Anton [1 ]
Auld, Douglas S. [1 ]
Thomas, Craig J. [1 ]
机构
[1] NHGRI, NIH, NIH Chem Genom Ctr, Rockville, MD 20850 USA
基金
美国国家卫生研究院;
关键词
caspases; covalent modifiers; cysteine proteases; inhibitors; VRT-043198; VX-765; INTERLEUKIN-1-BETA CONVERTING-ENZYME; CYSTEINE PROTEASES; INFLAMMATORY CASPASES; IMMUNE-RESPONSES; MECHANISM; TETRAZOLES; NITRILES; TARGETS; TBCATB; VX-765;
D O I
10.1002/cmdc.200900531
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein, we examine the potential of a nitrile-containing propionic acid moiety as an electrophile for covalent attack by the active-site cysteine residue of caspase 1. The syntheses of several cyanopropanate-containing small molecules based on the, optimized peptidic scaffold of prodrug VX-765 were accomplished. These compounds were found to be potent inhibitors of caspase 1 (IC50 values <= 1 nM). Examination of these novel small molecules against a caspase panel demonstrated an impressive degree of selectivity for caspase 1 inhibition over other caspase isozymes. Assessment of hydrolytic stability and selected ADME properties highlighted these agents as potentially useful tools for studying caspase 1 down-regulation in various settings, including in vivo analyses.
引用
收藏
页码:730 / 738
页数:9
相关论文
共 32 条
[1]  
BATCHELOR MJ, 1999, Patent No. 5874424
[2]   Targeting IL-1 in inflammatory disease: New opportunities for therapeutic intervention [J].
Braddock, M ;
Quinn, A .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :1-10
[3]  
CAPRATHE BW, 1999, Patent No. 1999056765
[4]   Inflammatory caspases: Targets for novel therapies [J].
Cornelis, Sigrid ;
Kersse, Kristof ;
Festjens, Nele ;
Lamkanfi, Mohamed ;
Vandenabeele, Peter .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (04) :367-385
[5]   Caspases: Keys in the ignition of cell death [J].
Denault, JB ;
Salvesen, GS .
CHEMICAL REVIEWS, 2002, 102 (12) :4489-4499
[6]   PEPTIDE ALDEHYDES AND NITRILES AS TRANSITION-STATE ANALOG INHIBITORS OF CYSTEINE PROTEASES [J].
DUFOUR, E ;
STORER, AC ;
MENARD, R .
BIOCHEMISTRY, 1995, 34 (28) :9136-9143
[7]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424
[8]   Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L [J].
Falgueyret, JP ;
Oballa, RM ;
Okamoto, O ;
Wesolowski, G ;
Aubin, Y ;
Rydzewski, RM ;
Prasit, P ;
Riendeau, D ;
Rodan, SB ;
Percival, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) :94-104
[9]   The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis [J].
Franchi, Luigi ;
Eigenbrod, Tatjana ;
Munoz-Planillo, Raul ;
Nunez, Gabriel .
NATURE IMMUNOLOGY, 2009, 10 (03) :241-247
[10]   Recent advances in the synthesis, design and selection of cysteine protease inhibitors [J].
Hernandez, AA ;
Roush, WR .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :459-465